Comparing Livent (LTHM) and Its Rivals

Share on StockTwits

Livent (NYSE: LTHM) is one of 28 public companies in the “Chemicals & allied products” industry, but how does it contrast to its peers? We will compare Livent to related businesses based on the strength of its earnings, dividends, institutional ownership, valuation, risk, profitability and analyst recommendations.

Valuation & Earnings

This table compares Livent and its peers gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Livent $442.50 million $126.10 million 7.62
Livent Competitors $7.49 billion $529.45 million 12.50

Livent’s peers have higher revenue and earnings than Livent. Livent is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a summary of current ratings for Livent and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Livent 2 6 6 0 2.29
Livent Competitors 232 788 1010 49 2.42

Livent currently has a consensus target price of $15.08, indicating a potential upside of 117.65%. As a group, “Chemicals & allied products” companies have a potential upside of 16.98%. Given Livent’s higher probable upside, equities analysts clearly believe Livent is more favorable than its peers.

Profitability

This table compares Livent and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Livent 19.88% 19.98% 14.87%
Livent Competitors -44.39% 20.06% 5.40%

Institutional & Insider Ownership

98.1% of Livent shares are owned by institutional investors. Comparatively, 72.3% of shares of all “Chemicals & allied products” companies are owned by institutional investors. 0.7% of Livent shares are owned by insiders. Comparatively, 8.9% of shares of all “Chemicals & allied products” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Livent peers beat Livent on 8 of the 12 factors compared.

Livent Company Profile

Livent Corporation manufactures and sells performance lithium compounds that are used primarily in energy storage, specialty polymers, and chemical synthesis application. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and supplies butyllithium, which is used as a synthesizer in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries. Livent Corporation was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.

Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Medtronic PLC  Expected to Post Quarterly Sales of $7.68 Billion
Medtronic PLC Expected to Post Quarterly Sales of $7.68 Billion
Systematic Financial Management LP Sells 5,787 Shares of WellCare Health Plans, Inc.
Systematic Financial Management LP Sells 5,787 Shares of WellCare Health Plans, Inc.
Systematic Financial Management LP Has $52,000 Holdings in United Continental Holdings Inc
Systematic Financial Management LP Has $52,000 Holdings in United Continental Holdings Inc
Warburg Research Analysts Give Patrizia Immobilien  a €23.00 Price Target
Warburg Research Analysts Give Patrizia Immobilien a €23.00 Price Target
Uniroyal Global Engineered Products  Upgraded by ValuEngine to Hold
Uniroyal Global Engineered Products Upgraded by ValuEngine to Hold
Weekly Investment Analysts’ Ratings Changes for Revolve Group
Weekly Investment Analysts’ Ratings Changes for Revolve Group


 
© 2006-2019 Zolmax.